Nanogen Completes Asset Sale to Elitech

The company said in a filing with the US Securities and Exchange Commission that the sale was closed following the completion of an auction process supervised by the court "in which Elitech emerged as the winning bidder."

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.